Harvey J. Alter

Q: What Schools Are Affiliated With Harvey J. Alter

Harvey J. Alter is affiliated with the following schools: George Washington University, Xiamen University, Nagoya City University, University of Southern California, Vanderbilt University, Georgetown University, University of Cagliari, University of Rochester

Harvey J. Alter's AcademicInfluence.com Rankings

Harvey J. Alter

Philosophy

#3418

World Rank

#5535

Historical Rank

#1090

USA Rank

Logic

#1148

World Rank

#1822

Historical Rank

#367

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Harvey J. Alter Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Harvey James Alter is an American medical researcher, virologist, physician and Nobel Prize laureate, who is best known for his work that led to the discovery of the hepatitis C virus. Alter is the former chief of the infectious disease section and the associate director for research of the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center in the National Institutes of Health in Bethesda, Maryland. In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A or hepatitis B viruses. Working independently, Alter and Edward Tabor, a scientist at the U.S. Food and Drug Administration, proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections, and that the causative agent was probably a virus. This work eventually led to the discovery of the hepatitis C virus in 1988, for which he shared the Nobel Prize in Physiology or Medicine in 2020 along with Michael Houghton and Charles M. Rice.

(See a Problem?)

Harvey J. Alter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis (1989) (2297)
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. (1989) (1655)
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. (1990) (1536)
Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent (1996) (1396)
A "NEW" ANTIGEN IN LEUKEMIA SERA. (1965) (1243)
Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus (1990) (1227)
A proposed system for the nomenclature of hepatitis C viral genotypes (1994) (1100)
National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C (1997) (1042)
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. (2000) (943)
Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. (2000) (770)
EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. (1999) (715)
Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 (2002) (683)
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis (1992) (646)
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. (1996) (626)
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. (1991) (595)
The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. (1997) (583)
Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis (1991) (579)
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. (1991) (572)
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. (1994) (515)
Neutralizing antibody response during acute and chronic hepatitis C virus infection. (2004) (462)
Lack of protective immunity against reinfection with hepatitis C virus. (1993) (435)
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. (1984) (435)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. (2007) (430)
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses (1994) (430)
Progression of fibrosis in chronic hepatitis C. (2003) (421)
Suppression of HCV‐specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection (2003) (406)
Lack of protective immunity against reinfection with hepatitis C virus (1992) (393)
Transfusion‐associated hepatitis not due to viral hepatitis type A or B † (1975) (390)
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes (1993) (379)
TRANSMISSIBLE AGENT IN NON-A, NON-B HEPATITIS (1978) (374)
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. (1976) (367)
Differential CD4+ and CD8+ T‐cell responsiveness in hepatitis C virus infection (2001) (364)
CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITIS (1975) (347)
Hepatitis C in hospital employees with needlestick injuries. (1991) (344)
A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades (2002) (336)
Long‐term mortality and morbidity of transfusion‐associated non‐A, non‐B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study (2001) (332)
Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. (1972) (320)
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. (1984) (319)
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. (1986) (317)
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). (1991) (317)
The hazards of blood transfusion in historical perspective. (2008) (314)
The cloning and clinical implications of HGV and HGBV-C. (1996) (294)
To C or not to C: these are the questions. (1995) (290)
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. (2005) (282)
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. (1979) (277)
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. (1978) (275)
Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic Features (1995) (264)
Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships. (1995) (260)
Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. (1982) (255)
Donor transaminase and recipient hepatitis. Impact on blood transfusion services. (1981) (250)
Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. (1990) (249)
The chronic sequelae of non-A, non-B hepatitis. (1979) (248)
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. (1996) (247)
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome (2002) (225)
Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors (2010) (202)
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. (1990) (198)
Non-A, non-B hepatitis in chimpanzees and marmosets. (1981) (194)
Effect of Hepatitis G Virus Infection on Chronic Hepatitis C (1996) (191)
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization (2008) (190)
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis (1990) (189)
Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. (1986) (180)
Experimental transmission of hepatitis B virus by semen and saliva. (1980) (180)
New kit on the block: Evaluation of second‐generation assays for detection of antibody to the hepatitis C virus (1992) (178)
Determining the size of non-A, non-B hepatitis virus by filtration. (1987) (176)
Hepatitis C virus-associated fulminant hepatic failure. (1996) (175)
Halothane Biotransformation in Man: A Quantitative Study (1967) (173)
Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long‐wavelength ultraviolet light (2005) (169)
Early events in hepatitis C virus infection of chimpanzees. (1990) (169)
Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. (2001) (169)
Increased detection of hepatitis C virus (HCV)‐infected blood donors by a multiple‐antigen HCV enzyme immunoassay (1992) (168)
Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study. (1989) (168)
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection (2003) (164)
NON-A, NON-B POST-TRANSFUSION HEPATITIS (1977) (156)
Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA (2000) (153)
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. (1987) (153)
Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. (1971) (151)
Effects of antiviral therapy on the cellular immune response in acute hepatitis C (2004) (151)
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma (2007) (147)
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. (1973) (146)
Failure to detect vertical transmission of hepatitis C virus (1992) (145)
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform (1983) (144)
Chronic Consequences of Non-A, Non-B Hepatitis (1989) (142)
Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity (2009) (140)
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. (1992) (139)
Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain (2008) (137)
G‐pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus (1997) (136)
Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. (2003) (134)
SEN virus infection and its relationship to transfusion‐associated hepatitis (2001) (131)
Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response (2003) (131)
Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen (1977) (130)
In vivo evaluation of the cross‐genotype neutralizing activity of polyclonal antibodies against hepatitis C virus (2011) (128)
IMPORTANCE OF WESTERN BLOT ANALYSIS IN PREDICTING INFECTIVITY OF ANTI-HTLV-III/LAV POSITIVE BLOOD (1985) (128)
Transfusion-associated hepatitis not due to viral hepatitis type A or B. 1975. (1975) (127)
Transfusion‐associated TT virus infection and its relationship to liver disease (1999) (125)
Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). (1995) (122)
Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis (2013) (122)
Effect of Hepatitis G Virus Infection on Progression of HIV Infection in Patients with Hemophilia (2000) (121)
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. (2006) (121)
A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection (2007) (114)
Humoral immune response to the E2 protein of hepatitis G virus is associated with long‐term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors (1997) (112)
Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors - An assessment of the efficacy of testing in donor screening (1990) (110)
HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear Fashion (2013) (109)
Landmark article Feb 15, 1965: A "new" antigen in leukemia sera. By Baruch S. Blumberg, Harvey J. Alter, and Sam Visnich. (1984) (107)
Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. (1998) (106)
Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. (1993) (105)
Emerging Infectious Diseases That Threaten the Blood Supply (2006) (104)
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. (1989) (104)
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity (2009) (104)
An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients (2013) (103)
Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA (1995) (103)
Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C? (1992) (102)
Hepatitis C in asymptomatic blood donors (1997) (98)
Failure to Confirm XMRV/MLVs in the Blood of Patients with Chronic Fatigue Syndrome: A Multi-Laboratory Study (2011) (96)
Descartes before the horse: I clone, therefore I am: the hepatitis C virus in current perspective. (1991) (95)
Prevalence and disease association of hepatitis G virus infection in Japan (1996) (94)
High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients (1992) (92)
HCV natural history: the retrospective and prospective in perspective. (2005) (91)
The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity (2003) (90)
Hepatitis C infection in children with hemophilia A and B. (1991) (89)
Health-care workers positive for hepatitis B surface antigen. Are their contacts at risk? (1975) (88)
The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. (2001) (86)
Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C (2016) (83)
Red cell autoantibodies in patients with acquired immune deficiency syndrome (1986) (82)
Microtiter solid-phase radioimmunoassay for hepatitis B antigen. (1973) (82)
Pathogen Reduction: A Precautionary Principle Paradigm (2008) (82)
Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. (2007) (81)
Further studies on a "new" human isoprecipitin system (Australia antigen). (1966) (80)
Infectious disease testing for blood transfusions. (1995) (80)
The immune response of healthy adults to a reduced dose of hepatitis B vaccine (1981) (79)
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. (2006) (78)
Public health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C (1991) (78)
WHAT DO WESTERN BLOT INDETERMINATE PATTERNS FOR HUMAN IMMUNODEFICIENCY VIRUS MEAN IN EIA-NEGATIVE BLOOD DONORS? (1989) (78)
Hepatitis C Virus and eliminating post-transfusion hepatitis (2000) (77)
Discovery of non-A, non-B hepatitis and identification of its etiology. (1999) (77)
The emerging pattern of post-transfusion hepatitis. (1975) (76)
Counterelectrophoresis for detection of hepatitis--associated antigen: methodology and comparison with gel diffusion and complement fixation. (1971) (74)
The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis (1990) (73)
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity (2005) (73)
The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg. (1976) (73)
The composition and environmental hazard of copper slags in the context of the Basel Convention (2005) (73)
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. (2007) (72)
Filler particle size and mechanical properties of polymers (1965) (71)
Probiotic‐associated high‐titer anti‐B in a group A platelet donor as a cause of severe hemolytic transfusion reactions (2009) (71)
Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. (2002) (69)
Serological markers of posttransfusion hepatitis C viral infection (1992) (69)
PHOTOCHEMICAL DECONTAMINATION OF BLOOD COMPONENTS CONTAINING HEPATITIS B AND NON-A, NON-B VIRUS (1988) (68)
Emerging infectious disease issues in blood safety. (2001) (66)
The recovery of plastics from waste with reference to froth flotation (2005) (65)
Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation. (1972) (65)
Transfusion‐Transmitted Hepatitis (2009) (65)
Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis. (1972) (64)
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. (2003) (64)
T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees (1987) (63)
A research agenda for curing chronic hepatitis B virus infection (2018) (61)
Management of the asymptomatic carrier of the hepatitis-associated (Australia) antigen. Tentative considerations of the clinical and public-health aspects. (1971) (61)
Viral hepatitis : 1981 international symposium (1982) (60)
A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus (2012) (59)
Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization (2003) (58)
Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology (2016) (57)
Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes. (2004) (57)
Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients (2003) (56)
Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis (1974) (56)
Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. (1992) (55)
Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization. (1999) (54)
Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus (2013) (54)
Relation of titers of antibodies to CMV in blood donors to the transmission of cytomegalovirus infection. (1984) (53)
TRANSFUSION TRANSMITTED HEPATITIS C AND NON‐A, NON‐B, NON‐C (1994) (53)
Licensure of screening tests for antibody to human T-lymphotropic virus type I. (1988) (52)
Multiple Antigenic Specificities of Serum Lipoproteins Detected with Sera of Transfused Patients (1964) (52)
Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection (2005) (52)
CIRCULATING IMMUNE COMPLEXES IN NON-A, NON-B HEPATITIS POSSIBLE MASKING OF VIRAL ANTIGEN (1979) (52)
Relation of hepatitis-B-antigen subtypes in symptom-free carriers to geographical origin and liver abnormalities. (1973) (49)
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue (2016) (49)
IgM antibody response in acute hepatitis C viral infection. (1992) (48)
Association between SEN virus infection and hepatitis C in Japan. (2001) (47)
Stability of HCV‐RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers (2001) (47)
Persistence and clinical significance of hepatitis G virus infections in injecting drug users. (1997) (47)
Seroprevalence of hepatitis C virus in the general population of northwest Tanzania. (2000) (45)
Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response. (1999) (45)
Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus)1 (2002) (45)
Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. (1995) (45)
URINARY EXCRETION OF BROMIDE IN HALOTHANE ANESTHESIA (1964) (45)
Transmission of hepatitis B virus infection by transfusion of frozen-deglycerolized red blood cells. (1978) (44)
Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization (2014) (44)
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy (2010) (44)
Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples (2010) (43)
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen. (1972) (43)
Hepatitis C: The End of the Beginning and Possibly the Beginning of the End (2012) (43)
SEN virus: epidemiology and characteristics of a transfusion‐transmitted virus (2005) (42)
Dynamics of SEN virus infection among injection drug users. (2001) (42)
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection (2021) (41)
Quantitative analysis of anti–hepatitis C virus antibody–secreting B cells in patients with chronic hepatitis C (2006) (41)
SEN virus: Response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C (2002) (41)
Risk of transfusing blood containing antibody to hepatitis-B surface antigen. (1974) (40)
The use of a recombinant immunoblot assay in the interpretation of anti‐ hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors (1991) (40)
Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies (2013) (40)
A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors. (2012) (40)
Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge (2015) (39)
Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion‐associated hepatitis: Final report of a prospective trial (1995) (39)
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis (2012) (39)
Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double‐stranded RNA (2007) (38)
Melanoma NOS1 expression promotes dysfunctional IFN signaling. (2014) (38)
Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. (2000) (36)
Strain analysis of hepatitis B virus on the basis of restriction endonuclease analysis of polymerase chain reaction products (1991) (36)
A critical investigation of polyethylene gas permeability (1962) (36)
Investigation of residual hepatitis C virus in presumed recovered subjects (2013) (35)
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice (2015) (35)
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations (2019) (34)
The Origins of Municipal Solid Waste: the Relations Between Residues From Packaging Materials and Food (1989) (33)
Clinical correlation and genetic polymorphism of the human immunodeficiency virus proviral DNA obtained after polymerase chain reaction amplification. (1990) (33)
Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis. (1985) (33)
Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases (1993) (32)
The Liver: Biology and Pathobiology: Fifth Edition (2009) (32)
Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. (1999) (32)
Interrelationship of rheumatoid arthritis, folic acid, and aspirin. (1971) (31)
Transmission of hepatitis B virus by artificial insemination (1988) (31)
Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost? (1995) (30)
Differential Responses of Plasmacytoid Dendritic Cells to Influenza Virus and Distinct Viral Pathogens (2014) (30)
Erratum: Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C (Gastroenterology (2003) 124 (352-360)) (2003) (30)
Ultrastructural Changes and Virus‐Like Particles Localized in Liver Hepatocytes of Chimpanzees Infected With Non‐A, Non‐B Hepatitis (1981) (28)
The history of refuse-derived fuels (1987) (27)
Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV. (2009) (27)
Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response (2014) (27)
The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells. (2013) (27)
Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees. (2006) (27)
Past and Present Hepatitis G Virus Infections in Areas Where Hepatitis C is Highly Endemic and Those Where It Is Not Endemic (1998) (27)
Transmission of hepatitis B virus by artificial insemination. (1987) (27)
The clinical relevance of persistent recombinant immunoblot assay–indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling (2012) (26)
Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants. (2008) (26)
The Economics of Resource Recovery from Municipal Solid Waste (1974) (26)
Industrial recycling and the Basel Convention (1997) (26)
Non-A, non-B hepatitis. (1976) (26)
Non-A, non-B viral hepatitis. (1981) (26)
Clinical, virological and epidemiological basis for the treatment of chronic non-A, non-B hepatitis. (1990) (25)
The dominant role of non-A, non-B in the pathogenesis of post-transfusion hepatitis: a clinical assessment. (1980) (24)
Spousal Transmission of the Hepatitis C Virus? (1994) (24)
The epidemiology of transfusion‐associated hepatitis C in a children's hospital (2007) (24)
Hepatitis B Antigen (HB Ag) and Antibody (Anti‐HB Ag) in Cold Ethanol Fractions of Human Plasma (1972) (23)
Discovery of the non-A, non-B hepatitis virus: the end of the beginning or the beginning of the end. (1989) (23)
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop (2017) (23)
Environmentally sound management of the recycling of hazardous wastes in the context of the Basel Convention (2000) (22)
Absence of transfusion‐associated microchimerism in pediatric and adult recipients of leukoreduced and gamma‐irradiated blood components (2012) (22)
A historical perspective on the discovery and elucidation of the hepatitis B virus. (2016) (22)
Randomized controlled trial of ionization and photoelectric smoke alarm functionality (2008) (21)
Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes. (2012) (21)
False positive tests for hepatitis-associated antigen in blood donors caused by antibodies to ruminant serum proteins. (1972) (21)
Editorial: Hepatitis B immune globulin: Evaluation of clinical trials and rationale for usage. (1975) (21)
The Ausria test: critical evaluation of sensitivity and specificity. (1973) (21)
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C (2018) (20)
Hepatitis-associated antigen. To test or not to test? (1970) (20)
Posttransfusion Hepatitis in the United States (1994) (20)
‘How Frequent is Posttransfusion Hepatitis after the Introduction of 3rd Generation Donor Screening for Hepatitis B? What is its Probable Nature?’ (1977) (20)
Evolutionary analysis of hepatitis C virus gene sequences from 1953 (2013) (20)
The Origins of Municipal Solid Waste: Ii. Policy Options for Plastics Waste Management (1993) (20)
The Nobel Assembly at Karolinska Institutet (2020) (20)
Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification (2015) (20)
Transfusion‐associated hepatitis before the screening of blood for hepatitis risk factors (2014) (19)
Lack of isolate‐specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV‐1‐infected patients (1993) (19)
Retraction for Lo et al., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors (2011) (19)
Emerging, re‐emerging and submerging infectious threats to the blood supply (2004) (19)
Infrared Analysis of Oxidized Keratin (1969) (19)
Indirect tests to detect the non-A, non-B hepatitis carrier state. (1984) (18)
Design models of trommels for resource recovery processing (1981) (18)
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies (2009) (18)
Thrombocytopenic purpura following vaccination with attenuated measles virus. (1968) (18)
Reversibility of experimental rabbit liver cirrhosis by portal collagenase administration (2005) (18)
Microtiter Solid-Phase Radioimmunoassay for Hepatitis B Antigen (1973) (17)
The road not taken or how I learned to love the liver: A personal perspective on hepatitis history (2014) (17)
The evolution, implications, and applications of the hepatitis B vaccine. (1982) (17)
The pathology of viral hepatitis in chimpanzees (2004) (17)
Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs. (2006) (16)
The unexpected outcomes of medical research: serendipity and the Australia antigen. Blumberg BS, Alter HJ, Visnich S. A new antigen in leukemia sera [J Am Med Assoc 1965;191:541-546]. (2003) (16)
The effect of adsorbed water on the critical surface tension of hair. (1969) (16)
Energy Conservation and Fuel Production by Processing Solid Wastes (1977) (16)
Blood system changes since recognition of transfusion‐associated AIDS (2013) (15)
Genomic scale analysis of racial impact on response to IFN-α (2009) (15)
Prevalence of Hepatitis G Virus in Patients with Hemophilia and Their Steady Female Sexual Partners (2000) (15)
The HBsAg positive health worker revisited (1981) (14)
Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group. (1990) (14)
DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response * (2004) (14)
Pilot study of interferon gamma for chronic hepatitis C (2003) (13)
Interpretation of pathogen load in relationship to infectivity and pathogen reduction efficacy (2018) (13)
Residential waste generation — A case study (1981) (13)
Serum hepatitis G virus RNA in patients with chronic viral hepatitis. (1997) (13)
Gamma-globulin for hepatitis-virus B. Prevention or extension? (1972) (13)
Transfusion-associated non-A, non-B hepatitis: an assessment of the causative agent and its clinical impact. (1988) (13)
Hepatitis C virus causing non-A, non-B hepatitis in plasmapheresis centre (1990) (13)
A Neutralization Epitope in the Hepatitis C Virus E2 Glycoprotein Interacts with Host Entry Factor CD81 (2014) (13)
Prevalence of hepatitis G virus (HGV) in Japan (1995) (13)
Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis. (1983) (12)
Hepatitis B and the health worker: prospective studies in perspective. (1976) (12)
A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation. (2007) (12)
Hepatitis C Virus Infection T Cells in Chronic + Virus-Specific CD8 Impaired Effector Function of Hepatitis C (2002) (12)
Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system (2016) (11)
SEN virus infection in patients with hepatocellular carcinoma (2005) (11)
Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis (2021) (11)
Molecular Structure as a Basis for Adhesion. Ultracentrifugal Measurement of the Adhesion of Epoxy Polymer (1958) (11)
Development of specifications for recycled products (1978) (11)
To have B or not to have B: vaccine and the potential eradication of hepatitis B. (2012) (11)
Non-A, non-B hepatitis: advances and unfulfilled expectations of the first decade. (1986) (11)
Solid Waste Conversion to Energy: Current European and U.S. Practice (1980) (11)
Stages in the progression of HIV infection in chimpanzees. (1987) (11)
Transfusion-transmitted HTLV-I/II infection in patients undergoing open- heart surgery (1990) (11)
An Epidemiologic Investigation of a Case of Acute Hepatitis E (2015) (11)
Changes in the infrared spectra of polymers in the vicinity of their glass transition (1968) (10)
The clinical significance of hepatitis B virus antigens and antibodies. (1975) (10)
Evaluation of commercially available and in-house reverse transcription-PCR assays for detection of hepatitis G virus or GB virus C (1997) (10)
Passive hemagglutination assay for antibody to subtypes of hepatitis B antigen. (1974) (10)
The Significance of Hepatitis G Virus in Serum of Patients With Sporadic Fulminant and Subfulminant Hepatitis of Unknown Etiology (1999) (10)
Materials Recovery from Municipal Waste: Unit Operations in Practice (1983) (10)
Materials and energy from refuse: Trends in the united states (1987) (10)
Genetic control of the murine humoral response to distinct epitopes of hepatitis C virus core protein (1995) (9)
The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology. (1999) (9)
What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? (1989) (9)
Prevalence of SEN viruses among injection drug users in the San Francisco Bay area. (2003) (9)
Autoimmune hepatitis type 1 without evidence of hepatitis G virus infection (1997) (8)
Should Donors with a History of Jaundice Still be Rejected (1981) (8)
Antibodies to Mycoplasma penetrans in HIV-infected patients (1993) (8)
Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus (2015) (8)
Is Elimination of Hepatitis B and C a Pipe Dream or Reality? (2019) (7)
Rheumatoid factor‐like reactants in sera proven to transmit non‐A, non‐B hepatitis: A potential source of false‐positive reactions in non‐A, non‐B assays (1985) (7)
Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery. (1990) (7)
Transmission Patterns in Hepatitis C Virus Infection (1994) (7)
Longitudinal Study of HTLV‐III‐Infected Chimpanzees by Lymphocyte Subpopulation Analysis (1985) (7)
Use of recombinant HCV antigen in the serodiagnosis of hepatitis C virus infection: Significant improvement in HCV antibody detection as compared with the first generation HCV C100‐3 ELISA and the synthetic peptide EIA tests (1993) (7)
Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C. (2016) (7)
Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease (2020) (7)
Application of the Critical Surface Tension Concept to Items in Our Everyday Life (1978) (7)
Cost of Recycling Municipal Solid Waste With and Without a Concurrent Beverage Container Deposit Law (1993) (7)
Energy recovery from municipal solid waste and method of comparing refuse-derived fuels (1975) (7)
[Metabolic products of halothane in urine]. (1966) (7)
Baruch Blumberg (1925–2011) (2011) (7)
Preparation and properties of densified refuse-derived fuel (1980) (6)
Energy Equivalents (1975) (6)
Risk Management in Blood Transfusion: The Virtue of Reality (1999) (6)
Disposal and recovery of municipal solid waste: Michael E. Henstock, editor. Butterworths, Woburn, MA 01810. 1983. 194 pp., $49.95. cloth (1983) (6)
Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors. (2021) (6)
Porphyria cutanea tarda in hepatitis C virus-infected blood donors. (1995) (6)
Binding of Free and Immune Complex‐Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System (2018) (6)
Transmission of LAV/HTLV-III by blood products (1987) (6)
Hepatitis‐Associated Antigen and Antibody in Cold Ethanol Fractionates of Human Blood (1971) (6)
Intranasal drug use among volunteer whole‐blood donors: results of Survey C (1998) (6)
Impaired effector function of HCV-specific CD8+ T cells in chronic hepatitis C virus infection (2001) (6)
AN ALKYLATING AGENT FOR MULTIPLE MYELOMA: MELPHALAN. (1965) (5)
HCV Infection Alters Salivary Gland Histology and Saliva Composition (2022) (5)
Isolation of Human Monoclonal Antibodies to the Envelope E2 Protein of Hepatitis C Virus and Their Characterization (2013) (5)
CheITlical Analyses of the Organic Portions of Household Refuse ; the Effect of Certain Elements on Incineration and Resource Recovery (2010) (5)
HCV: The Journey from Discovery to a Cure: Volume I (2019) (5)
A Data Retrieval System for Blood Donor Information (1965) (5)
The Melting of Keratin (1969) (5)
Is Elimination of Hepatitis B and C a Pipe Dream or Reality? (2018) (5)
Viral Hepatitis Markers in Soviet and American Blood Donors (1980) (5)
Resource recovery: Technical and economic risks☆ (1980) (5)
Time for the Elimination of Hepatitis C Virus as a Global Health Threat (2020) (5)
A method of planning resource recovery in a developing country to deal with uncertainty (1989) (4)
PCR‐probe capture hybridization assay and statistical model for SEN virus prevalence estimation (2004) (4)
Critical review of energy recovery from solid wastes (1984) (4)
Understanding the natural history of chronic HBV and HCV infections. (2010) (4)
Recovery and reuse — mechanical processing (1980) (4)
Identification of a murine CD4+ T-lymphocyte response site in hepatitis C virus core protein. (1996) (4)
An unexpected link between HCV and platelets. (2001) (4)
The gelation of plastisols: An automatic method for the determination of plastisol temperature‐rheology characteristics (1959) (4)
Reply to Erlwein et al. and Martin: On detection of murine leukemia virus-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors (2010) (4)
Detection of antibodies to single‐stranded dna in naturally acquired and experimentally induced viral hepatitis (1980) (4)
Viral hepatitis. Light at the end of the tunnel. (1974) (3)
Comparison of four different antigen-capture assays for the detection of human immunodeficiency virus antigen (HIV-Ag). (1989) (3)
Exposure to a food-handler with hepatitis B. (1972) (3)
The Evolution of a Polyurethane Dental Adhesive System (1971) (3)
Sexual transmission of HCV and posible role of coexistent HIV infection in the index cases (1991) (3)
Non-A, non-B hepatitis. 1976. (2000) (3)
Hepatology highlights (2002) (3)
The relationship between hepatitis B virus infection and hepatic cell carcinoma in Mozambique. (1977) (3)
Municipal solid waste as a resource for energy recovery and conservation (1976) (2)
Hepatitis B viral infection: part I. Clinical features. (1982) (2)
A microarray-based pathogen chip for simultaneous molecular detection of transfusion–transmitted infectious agents (2019) (2)
Non-A,Non-BHepatitis (1976) (2)
Making resource recovery economical (1980) (2)
THE GORDON WILSON LECTURE: THE HEPATITIS C VIRUS: FROM HIPPOCRATES TO CURE. (2019) (2)
A study of street heroin lots for the presence of the hepatitis B surface antigen. (1978) (2)
Reflections on the History of HCV: A Posthumous Examination (2020) (2)
Current status of posttransfusion hepatitis. (1980) (2)
Idiopathic inflammatory myopathy. Failure to detect hepatitis B antigen in serum and muscle. (1973) (2)
Analysis of newsprint recovered from mixed municipal waste (1976) (2)
Hepatitis B viral infection: Part II. Public health aspects. (1982) (2)
Subtypes of HBsAg in Eastern and South‐Eastern Europe (1977) (2)
Specifications for materials recovered from municipal refuse. Final report (1975) (2)
Transfusion-Associated NonA , Non-B Hepatitis : The First Decade (2012) (2)
New viruses and their relationship to hepatitis (2003) (2)
Packaging and the environment. Alternatives, trends and solutions: S.E. Selke, Technomic Publishing Co., Inc. Basel, 1990. xi + 179 pp. hardcover, price SFr. 84 (1992) (2)
Toward a national policy for secondary materials (1982) (2)
Polymer microscopy and morphology by an improved technique (1963) (2)
The case against transfusion‐transmitted non‐ABC hepatitis (2018) (2)
Corrigendum to “The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells” [Virology 438 (2013) 28–36] (2013) (2)
Probable visualization of the elusive hepatitis C virus. (1993) (1)
INFECTION AND INFECTION CONTROL (Including Disinfectants) (1975) (1)
Everybody wants clean air (1987) (1)
Preparation of densified refuse-derived fuel on a pilot scale (1978) (1)
Serological Markers ofPosttransfusion Hepatitis C Viral Infection (1992) (1)
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants (2022) (1)
From B to Non-B to C: The Hepatitis C Virus in Historical Perspective (2019) (1)
patients (see comments) Prevalence of hepatitis C virus antibody in a cohort of hemophilia (2013) (1)
Genomic scale analysis of NK cells impact on response to IFN-α (2013) (1)
Comprar The Liver: Biology and Pathobiology | Georgios Kontogeorgis | 9780470723135 | Wiley (2009) (1)
A conserved epitope III on hepatitis C virus E2 protein has alternate conformations facilitating cell binding or virus neutralization (2021) (1)
A "New" Antigen inLeukemia Sera (2015) (1)
From the National Institute of Allergy and Infectious Diseases Factors Associated with the Pathogenesis of AIDS (1987) (1)
TESTING FOR HUMAN IMMUNODEFICIENCY VIRUS P24 ANTIGEN. AUTHORS' REPLIES (1996) (1)
Management of hepatitis virus infections (2008) (1)
Differences in color vision deficiencies induced by various cardiac glycosides. (1982) (1)
First world congress on recycling, Basle, Switzerland, 6–8 March 1978 (1979) (1)
A2 Molecular Evolution of Hepatitis C Virus (HCV) and Clinical Outcome in Patients With Hepatitis C (2012) (1)
Coatings wastes as energy sources (1974) (1)
Application of Bond Theory to Solid Waste Shredding (1978) (1)
Book reviewSolid wastes: Origin, collection, processing and disposal: Edited by C.L. Mantell, John Wiley, New York, 1975, 1127 pages, price $47.50 (1978) (0)
A microarray-based pathogen chip for simultaneous molecular detection of transfusion–transmitted infectious agents (2019) (0)
Book reviewWörterbuch der industriellen technik: R. Ernst: O. Brandstetter Verlag K.G., Wiesbaden. Band I: Deutsch-Englisch, 1061 pp. Band II: Englisch-Deutsch, 1146 pp. Price DM 100, each. (1978) (0)
Hepatology highlights (2005) (0)
Hepatology highlights (2005) (0)
New home buyer noise reduction listening study. (2008) (0)
Newer Methods of Polymer Characterization. Bacon Ke, Ed. Interscience (Wiley), New York, 1964. xvi + 722 pp. Illus. $22.50 (1964) (0)
Magnetic separation: recovery of saleable iron and steel from municipal waste (1977) (0)
The significance and error of polymer adhesion measurements with the ultracentrifuge (1961) (0)
A Survey of U. S. and European Practices for Recovering Energy from Municipal Waste (1979) (0)
A jury study of noise isolation between condo units incorporating QuietZone® acoustic wall framing in the common wall (2006) (0)
Hepatology highlights (2004) (0)
Hepatitis C (HCV) (2019) (0)
Hepatology highlights (2005) (0)
Hepatitis G virus infection in blood donors with positive screening test for hepatitis C virus antibody (1998) (0)
Diminished Replication and Viral Compartmentalization of Hepatitis C Virus in Hepatocellular Carcinoma Tissue (2016) (0)
HIV-infected chimpanzees. virus (HIV) and its recombinant antigens in T-cell responses to human immunodeficiency (2013) (0)
Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus (2015) (0)
G105 Profibrogenic Chemokines and Viral Evolution Predict Rapid Progression of Hepatitis C to Cirrhosis (2013) (0)
Foreword (2007) (0)
Why Did The Discovery of Hepatitis C Virus Win The Nobel Prize? (2020) (0)
components containing antibody to hepatitis C Evidence of hepatitis in patients receiving transfusions of blood (2003) (0)
False pasitive results using commercial RT-PCR for hepatitis C virus (HCV) RNA: frequency and impact on clinical management (2001) (0)
The Repli-Con Game (2003) (0)
1 HIV Populations are Large and Accumulate High Genetic Diversity in Nonlinear (2013) (0)
Hepatology highlights (2002) (0)
Steatosis and Fibrosis: Fat or Fiction? (2002) (0)
Technics of HAA detection. (1972) (0)
The hepatitis-associated antigen. (Australia antigen). (1971) (0)
Strain-Speciﬁc T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection (2005) (0)
What a Dumb Way to Designate Germs (1994) (0)
O.034 Emerging infections that threaten the blood supply (2006) (0)
Hepatology highlights (2004) (0)
Failure to transmit human viral hepatitis types A and B to the congenitally athymic nude mouse. (1977) (0)
Comprar Clinical Trials in Psychopharmacology: A Better Brain | Irwin Arias | 9780470740767 | Wiley (2010) (0)
Presence of a novel SEN-virus in patients with liver diseases and blood donors in Japan (2001) (0)
Absence ofautoimmune serological reactions in chronic nonA,nonBviral hepatitis (1985) (0)
Viral hepatitis (2006) (0)
Hepatology highlights† (2006) (0)
Some approaches to deciding HB Ag (Australia antigen) positivity by counterimmunoelectrophoresis (1974) (0)
Préface The past is prologue: the profundity, productivity and progress of the early HBV years (2020) (0)
The Impact of Race on Interferon-α Responsiveness: A Genome-wide Study (2010) (0)
Does Blood with Antibodies against Hepatitis B Carry an Increased Risk to Transmit Hepatitis? (1975) (0)
Hepatology highlights (2003) (0)
64 Effect of early antiviral therapy on the cellular immune response in acute hepatitis C (2003) (0)
Hepatology highlights (2003) (0)
the Transmission of Cytomegalovirus Infection (1984) (0)
Hepatology highlights (2006) (0)
Hepatology highlights (2002) (0)
Discovery of tbe Non-A, Non-B Hepatitis Virus: Tbe End of tbe Beginning or tbe Beginning of tbe End (1989) (0)
H-108 Special lecture in honor of Ray Schinazi: The HCV story (2017) (0)
Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy. (2023) (0)
Hepatology highlights (2005) (0)
No Observed Risk of Pregnancy and Maternal-Fetal Transmission of Zika Virus Following Blood Transfusion (2019) (0)
Testing for human immunodeficiency virus p24 antigen (1996) (0)
Hepatology highlights (2006) (0)
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative (2023) (0)
Fulminant and Subfulminant Hepatitis of Unknown Etiology The Significance of Hepatitis G Virus in Serum of Patients With Sporadic (2012) (0)
161-P: KIR genes and response to HCV infection in caucasoid patients (2006) (0)
ISVHLD 2006 (2007) (0)
Hepatitis C in Chimpanzees and Humans (1994) (0)
A functional SNP of interferon- (cid:1) gene is important for interferon- (cid:2) -induced and spontaneous recovery from hepatitis C virus infection (2007) (0)
Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology (2016) (0)
OL1: Keeping blood safe – a global challenge (2014) (0)
Hepatology highlights (2003) (0)
Hepatology highlights (2004) (0)
Blood Donors with Antibody to Hepatitis C Virus (1996) (0)
Probable visualization of the elusive hepatitis C virus (1993) (0)
Back to the Future: A Backward Glance at the Forward Progress of Hepatitis Virus Research (2009) (0)
Constituent hepatitis b surface antigen polypeptides of hepatitis b virus infected patients (1985) (0)
Hepatology highlights (2002) (0)
Corrigendum to “Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease” (2020) (0)
Hepatitis C virus – from Hippocrates to cure (2016) (0)
THU-154-Low rate of hepatitis B reactivation among patients with chronic hepatitis C during direct acting antiviral therapy (2019) (0)
Erratum: A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, (985-990) DOI: 10.1073/pnas.0609954104) (2007) (0)
KL1: The risk of developing cancer following successful treatment for hepatitis (2014) (0)
News and Views December 2020 (2020) (0)
NOS1 overexpression by melanoma cells contributes to type I IFN alpha signal dysfunction in immune cells (2012) (0)
Risk of Transfusion-Transmitted Infection: A Comparative Analysis of Then and Now (1999) (0)
Polymer Reviews: Newer Methods of Polymer Characterization . Bacon Ke, Ed. Interscience (Wiley), New York, 1964. xvi + 722 pp. Illus. $22.50. (1964) (0)
Hepatitis Non A Non B: A Newly Recognized Old Disease (1983) (0)
Sound transmission class (STC) is not a good predictor of performance of insulated wood frame gypsum walls used as interior partitions in most North American homes (2005) (0)
Measurement of plastisol gelation and solution by infrared spectroscopy (1965) (0)
Hepatitis E prevalence and infection in solid‐organ transplant recipients in the United States (2022) (0)
To Be B or Not to Be B? No Longer the Question in Hepatitis B (2002) (0)
[Investigation into the efficacy of filters for absorption of anaesthetic cases (author's transl)]. (1973) (0)
Auswirkung von frühzeitiger antiviraler Therapie auf die Kinetiken der zellulären Immunantwort und der Viruslast bei akuter Hepatitis C Infektion (2004) (0)
Resource recovery and utilization : proceedings of the National Materials Conservation Symposium : a symposium (1975) (0)
[Combined Epontol anesthesia, especially appropriate for the gynecologic examination course for students]. (1969) (0)
Hepatology highlights (2003) (0)
Peripheral B cells from patients with hepatitis C virus-associated lymphoma exhibit clonal expansion and an anergic-like transcriptional profile (2022) (0)
The N number, a speech privacy metric for rating walls, revisited (2007) (0)
Waste disposal management and practice: by John Skitt, Charles Knight & Company Ltd., London (1979) 216 pp (1982) (0)
‘‘Sound’’ science and technical education for sixth graders: A practical approach (2000) (0)
Processing and reuse of municipal waste for energy production (1981) (0)
Letter To the Editor (1990) (0)
Nobelpreis für Transfusionsmediziner – entscheidender Meilenstein (2020) (0)

This paper list is powered by the following services:

Other Resources About Harvey J. Alter

en.wikipedia.org

What Schools Are Affiliated With Harvey J. Alter?

Harvey J. Alter is affiliated with the following schools:

Harvey J. Alter's Academic­Influence.com Rankings